Citations for
1HSP90AA1, PRKD2
HSP90 supports tumor growth and angiogenesis through PRKD2 protein stabilization.
Azoitei N, Diepold K, Brunner C, Rouhi A, Genze F, Becher A, Kestler H, van Lint J, Chiosis G, Koren J 3rd, Fröhling S, Scholl C, Seufferlein T.
Cancer Res 74(23):7125-36. doi: 10.1158/0008-5472.CAN-14-1017. Epub 2014 Oct 8. 2014
2MMP9, PRKD2, VEGFA
Protein kinase D2 induces invasion of pancreatic cancer cells by regulating matrix metalloproteinases.
Wille C, Köhler C, Armacki M, Jamali A, Gössele U, Pfizenmaier K, Seufferlein T, Eiseler T.
Mol Biol Cell 25(3):324-36. doi: 10.1091/mbc.E13-06-0334. Epub 2013 Dec 11. 2014
3GOLPH3, PRKD2
Protein kinase D2 promotes the proliferation of glioma cells by regulating Golgi phosphoprotein 3.
Zhou X, Xue P, Yang M, Shi H, Lu D, Wang Z, Shi Q, Hu J, Xie S, Zhan W, Yu R.
Cancer Lett 355(1):121-9. doi: 10.1016/j.canlet.2014.09.008. Epub 2014 Sep 16. 2014
4PRKD2
HSP90 supports tumor growth and angiogenesis through PRKD2 protein stabilization.
Azoitei N, Diepold K, Brunner C, Rouhi A, Genze F, Becher A, Kestler H, van Lint J, Chiosis G, Koren J 3rd, Fröhling S, Scholl C, Seufferlein T.
Cancer Res 74(23):7125-36. doi: 10.1158/0008-5472.CAN-14-1017. Epub 2014 Oct 8. 2014
5CIB1, PRKD2
A novel splice variant of calcium and integrin-binding protein 1 mediates protein kinase D2-stimulated tumour growth by regulating angiogenesis.
Armacki M, Joodi G, Nimmagadda SC, de Kimpe L, Pusapati GV, Vandoninck S, Van Lint J, Illing A, Seufferlein T.
Oncogene 33(9):1167-80. doi: 10.1038/onc.2013.43. Epub 2013 Mar 18. 2014
6GABPA, GABPB1, GABPB2, PRKD2
GABP transcription factor is required for development of chronic myelogenous leukemia via its control of PRKD2.
Yang ZF, Zhang H, Ma L, Peng C, Chen Y, Wang J, Green MR, Li S, Rosmarin AG.
Proc Natl Acad Sci U S A 110(6):2312-7. doi: 10.1073/pnas.1212904110. Epub 2013 Jan 23. 2013
7BCL6B, HSP90AB1, PRKD2, VEGFA
Protein kinase D2 and heat shock protein 90 beta are required for BCL6-associated zinc finger protein mRNA stabilization induced by vascular endothelial growth factor-A.
Miwa D, Sakaue T, Inoue H, Takemori N, Kurokawa M, Fukuda S, Omi K, Goishi K, Higashiyama S.
Angiogenesis 16(3):675-88. doi: 10.1007/s10456-013-9345-x. Epub 2013 Mar 21. 2013
8PRKD1, PRKD2, PRKD3, RHOA, RTKN
Protein kinase D regulates RhoA activity via rhotekin phosphorylation.
Pusapati GV, Eiseler T, Rykx A, Vandoninck S, Derua R, Waelkens E, Van Lint J, von Wichert G, Seufferlein T.
J Biol Chem 287(12):9473-83. doi: 10.1074/jbc.M112.339564. Epub 2012 Jan 6. 2012
9PRKD2
Protein kinase D2 has a restricted but critical role in T-cell antigen receptor signalling in mature T-cells.
Navarro MN, Sinclair LV, Feijoo-Carnero C, Clarke R, Matthews SA, Cantrell DA.
Biochem J 442(3):649-59. doi: 10.1042/BJ20111700. 2012
10PRKD2, SET
Phosphorylation of SET protein at Ser171 by protein kinase D2 diminishes its inhibitory effect on protein phosphatase 2A.
Irie A, Harada K, Araki N, Nishimura Y.
PLoS One 7(12):e51242. doi: 10.1371/journal.pone.0051242. Epub 2012 Dec 14. 2012
11ASAP1, PRKD2, RAB5C
Rab5c promotes AMAP1-PRKD2 complex formation to enhance β1 integrin recycling in EGF-induced cancer invasion.
Onodera Y, Nam JM, Hashimoto A, Norman JC, Shirato H, Hashimoto S, Sabe H.
J Cell Biol 197(7):983-96. doi: 10.1083/jcb.201201065. 2012
12PRKD1, PRKD2
Protein kinase D isoforms are activated in an agonist-specific manner in cardiomyocytes.
Guo J, Gertsberg Z, Ozgen N, Sabri A, Steinberg SF.
J Biol Chem 286(8):6500-9. Epub 2010 Dec 14. 2011
13IFNAR1, PRKD2
Ligand-stimulated downregulation of the alpha interferon receptor: role of protein kinase D2.
Zheng H, Qian J, Varghese B, Baker DP, Fuchs S.
Mol Cell Biol 31(4):710-20. doi: 10.1128/MCB.01154-10. Epub 2010 Dec 20. 2011
14PRKD1, PRKD2
Unique functions for protein kinase D1 and protein kinase D2 in mammalian cells.
Matthews SA, Navarro MN, Sinclair LV, Emslie E, Feijoo-Carnero C, Cantrell DA.
Biochem J 432(1):153-63. doi: 10.1042/BJ20101188. 2010
15PRKD1, PRKD2, SLC9A3R1, SLC9A3R2
The protein scaffold NHERF-1 controls the amplitude and duration of localized protein kinase D activity.
Kunkel MT, Garcia EL, Kajimoto T, Hall RA, Newton AC.
J Biol Chem 284(36):24653-61. Epub 2009 Jul 6.PMID: 19581308 2009
16LCK, PRKD2
PKD2 interacts with Lck and regulates NFAT activity in T cells.
Li Q, Sun X, Wu J, Lin Z, Luo Y.
BMB Rep 42(1):35-40. 2009
17PRKD2
Protein kinase D2 regulates chromogranin A secretion in human BON neuroendocrine tumour cells.
von Wichert G, Edenfeld T, von Blume J, Krisp H, Krndija D, Schmid H, Oswald F, Lother U, Walther P, Adler G, Seufferlein T.
Cell Signal 20(5):925-34. Epub 2008 Jan 16. 2008
18PRKD2
Overexpression of wild-type PKD2 leads to increased proliferation and invasion of BON endocrine cells.
Jackson LN, Li J, Chen LA, Townsend CM, Evers BM.
Biochem Biophys Res Commun 348(3):945-9. Epub 2006 Jul 31. 2006
19PRKD2
Role of the regulatory domain of protein kinase D2 in phorbol ester binding, catalytic activity, and nucleocytoplasmic shuttling.
Auer A, von Blume J, Sturany S, von Wichert G, Van Lint J, Vandenheede J, Adler G, Seufferlein T.
Mol Biol Cell 16(9):4375-85. Epub 2005 Jun 22. 2005
20PRKD2
Protein kinase D regulates basolateral membrane protein exit from trans-Golgi network.
Yeaman C, Ayala MI, Wright JR, Bard F, Bossard C, Ang A, Maeda Y, Seufferlein T, Mellman I, Nelson WJ, Malhotra V.
Nat Cell Biol 6(2):106-12. Epub 2004 Jan 25. 2004
21PRKD2
Molecular cloning and characterization of the human protein kinase D2. A novel member of the protein kinase D family of serine threonine kinases.
Sturany S, Van Lint J, Muller F, Wilda M, Hameister H, Hocker M, Brey A,Gern U, Vandenheede J, Gress T, Adler G, Seufferlein T.
J Biol Chem 276(5):3310-8. Epub 2000 Nov 02. 2001